NEW YORK (GenomeWeb News) – Life Technologies disclosed in a filing with the US Securities and Exchange Commission yesterday that it has requested a waiver under an existing credit agreement with lenders dated Nov. 21, 2008.

If approved, the waiver would enable Life Technologies to incur indebtedness in the form of unsecured, fixed-rate or floating-rate securities, in one or more series. The firm would use the proceeds to prepay term loan indebtedness under the credit agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.